Antitope, Rottapharm Madaus deal

Antitope said it completed a research deal with Rottapharm's antibody unit Rottapharm Biotech s.r.l. to profile the immunogenicity of Rottapharm's CRB0017. Under the deal, Antitope applied its EpiScr...